Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00367796
Other study ID # 999905072
Secondary ID 05-HG-N072
Status Completed
Phase N/A
First received August 22, 2006
Last updated June 30, 2017
Start date January 5, 2005
Est. completion date December 23, 2008

Study information

Verified date December 23, 2008
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will try to find the gene changes responsible for the birth defects in craniosynostosis, Philadelphia type. Craniosynostosis syndromes are a group of conditions that result from closure of one or more of the fibrous joints between the bones of the skull before brain growth is complete. Because of the premature closure, the brain is not able to grow in its natural shape; instead, it compensates with growth in areas of the skull where the joints have not yet closed. The defects in raniosynostosis, Philadelphia type, include skull malformations and webbing of the fingers and toes. Gene changes known to be involved in other craniosynostosis syndromes have not been found in the Philadelphia type syndrome. Therefore, finding the genetic basis of this disorder will provide important new information regarding craniofacial and limb development.

This study includes members of a single large family affected with craniosynostosis, Philadelphia type.

Participants have 1 to 2 teaspoons of blood drawn for genetic studies. A second blood sample may be requested for further research. Some blood may be used to establish a cell line for later studies. This involves growing the white blood cells from the blood sample. The cells can be kept in the laboratory to make more DNA or can be frozen for later use in craniosynostosis studies. Patients may also have their medical records reviewed.


Description:

The objective of this study is to determine the molecular basis of craniosynostosis, Philadelphia type. Previous studies by our lab have excluded FGFR1, FGFR2 and FGFR3, the causative genes of most hereditary craniosynostosis syndromes. In the five generation kindred previously reported we have conducted a genome-wide linkage analysis. We have identified four regions linked to this disorder, namely on 2q, 12q, 20q and 22q. Interestingly, syndactyly 1A, a phenotypically similar disorder, demonstrates an overlapping linkage region in two studies. Screening of candidate genes in the redion has excluded ten candidate genes, including IHH, IGFBP2 and IGFBP5.

This protocol is primarily for research purposes. Research subjects may receive benefit from knowing that this research may help other families in the future. Results will be discussed with the primary physician who is a trained medical geneticist. We will emphasize that these are only preliminary findings, that they are not CLIA-approved, and must not be disclosed to the patient or included in the medical record. Repeat testing in a CLIA-approved lab would be required before the specific genetic information could be shared with the patient and family.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date December 23, 2008
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility - INCLUSION CRITERIA:

This research includes only craniosynostosis Philadelphia type patients and members of a single family who were previously referred to us and other family members who have since displayed interest in participating in this study.

EXCLUSION CRITERIA:

Anyone unwilling to provide informed consent (for themselves as adults, or on behalf of their children as minors) or assent.

Medical condition(s) are not in themselves reason for exclusion if in the judgment of the referring physician this would involve no more than minimal risk.

We generally reviewed a brief clinical description from the referring physician about a potential research subject to determine that the subject was appropriate to enter into the study. We reserved the right to exclude cases that were clearly not related to our direct research interests. For new participants, we will review the clinical description from the referring physician and we reserve the right to exclude cases.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Childrens Hospital, Philadelphia Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
National Human Genome Research Institute (NHGRI)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Bosse K, Betz RC, Lee YA, Wienker TF, Reis A, Kleen H, Propping P, Cichon S, Nöthen MM. Localization of a gene for syndactyly type 1 to chromosome 2q34-q36. Am J Hum Genet. 2000 Aug;67(2):492-7. Epub 2000 Jun 30. — View Citation

Ghadami M, Majidzadeh-A K, Haerian BS, Damavandi E, Yamada K, Pasallar P, Najafi MT, Nishimura G, Tomita HA, Yoshiura KI, Niikawa N. Confirmation of genetic homogeneity of syndactyly type 1 in an Iranian family. Am J Med Genet. 2001 Nov 22;104(2):147-51. — View Citation

Robin NH, Segel B, Carpenter G, Muenke M. Craniosynostosis, Philadelphia type: a new autosomal dominant syndrome with sagittal craniosynostosis and syndactyly of the fingers and toes. Am J Med Genet. 1996 Mar 15;62(2):184-91. — View Citation

See also
  Status Clinical Trial Phase
Withdrawn NCT00769847 - Endoscopic Treatment for Isolated, Single Suture Craniosynostosis N/A
Completed NCT00077831 - Child and Infant Learning Project N/A
Recruiting NCT03231085 - Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child N/A
Active, not recruiting NCT02229968 - Efficacy of Amicar for Children Having Craniofacial Surgery Phase 2
Completed NCT02287805 - Qualitative and Quantitative Study Which Aims to Determine the Specifics of the Announcement for the Diagnosis of Patients With Craniosynostosis and Their Parents to Better Support Them in Their Care N/A
Enrolling by invitation NCT05911139 - Influence of General Anesthesia on the Dynamic Changes in Brain Damage Markers During and After Craniosynostosis Operations in Infancy
Completed NCT00912119 - Amicar Pharmacokinetics of Children Having Craniofacial Surgery Phase 1
Completed NCT00106977 - Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)
Withdrawn NCT02561728 - Hanger Helmet Study N/A
Terminated NCT00722436 - Tranexamic Acid for Craniofacial Surgery Phase 4
Completed NCT01898650 - MRI for Non-invasive Evaluation of Brain Stress N/A
Active, not recruiting NCT03025763 - Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones
Completed NCT02188576 - The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery Phase 4
Completed NCT00773643 - Osteogenic Profiling of Tissue From Children With Craniosynostosis N/A
Enrolling by invitation NCT04704284 - Comparing MRI to CT on Pediatric Craniosynostosis. N/A